Clinical Trials Browser

Phase 4 × Brain Neoplasms × 90 days × Clear all

NCT06282874 2026-04-09

Lorlatinib in Patients With ALK-Positive NSCLC With Brain or Leptomeningeal Metastases

Phase 4 Active not recruiting

Brain Neoplasms, Carcinoma, Non-Small-Cell Lung, Meningeal Carcinomatosis

NCT04266665 2026-03-25

Effect of Dexmedetomidine on Brain Homeostasis and Neurocognitive Outcome

Phase 4 Completed

Neuroinflammatory Diseases, Hypoxia, Brain Neoplasms